BETHANY SIRIANNI-JONES: Open Payments
NPI 1124527023 · LEWISTON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,374 in 71 payments from 22 companies in 2025. Trend: 2023 $1,756 · 2024 $1,955 · 2025 $1,374
Food & beverage: $1,374
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 10 | $194 |
| Novo Nordisk Inc | 9 | $155 |
| GlaxoSmithKline, LLC. | 7 | $131 |
| ABBVIE INC. | 5 | $109 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $105 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $92 |
| PFIZER INC. | 5 | $88 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $72 |
| Astellas Pharma US Inc | 2 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $49 |
Products named: JARDIANCE, Ozempic, TRELEGY ELLIPTA, MOUNJARO, CAPLYTA, UBRELVY, Kerendia, Veozah.
Industry payments across NY — which companies pay providers there.
